EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Association of Lactate‐to‐Albumin Ratio With 28‐Day Mortality in Critically Ill Patients With Obstructive Sleep Apnea: A Retrospective Cohort Study Based on the MIMIC‐IV Database

Jian Zhou iD, Chuntian Chi iD, Fanghao Yu iD, Junpei Wu iD, Hanjian Lou iD

Canadian Respiratory Journal · 2026-01 · 2026 (1)

DOI: 10.1155/carj/6582764 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Canadian Respiratory Journal, online erschienen am 05.11.2026. Verfasst von Jian Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Yiwu Central Hospital, Yiwu, Zhejiang, China, ywzxyy.com. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Critical Illness, Lactic Acid, Serum Albumin. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yiwu Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obstructive sleep apnea (OSA) is not uncommon among critically ill patients, especially in those with acute hypercapnic respiratory failure. Its high mortality rate remains a major challenge in the intensive care setting. The frequent apnea and respiratory failure during sleep in OSA patients, along with the intermittent hypoxemia caused by it, are accompanied by a series of systemic pathological and physiological changes. Metabolic imbalance is a key characteristic of the underlying pathological mechanism of this disease. However, the association between lactate‐to‐albumin ratio (LAR) and the prognosis of OSA patients remains to be fully elucidated. To date, a paucity of studies has evaluated the prognostic capabilities of these indicators. The majority of these studies have focused on the neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR), and the results are contradictory, insufficient to fully clarify their clinical significance. Relying solely on lactate may not fully reflect patients’ physiological conditions, whereas integrating LAR can provide a more comprehensive and accurate description of the metabolic state. This study aims to explore the relationship between LAR and 28‐day mortality rates in ICU patients with OSA, using data from the MIMIC‐IV database.

Methods

Patients diagnosed with OSA were selected from the Medical Information Mart for Intensive Care IV (v.2.2) database, identified by specific ICD‐9 and ICD‐10 codes (detailed in the Methods section). To assess the predictive power of LAR, receiver operating characteristic (ROC) curve analysis, Kaplan–Meier (K‐M) survival curve analysis, logistic regression analysis, and subgroup analysis were employed. LAR was analyzed both as a categorical variable (based on the optimal cutoff) and as a continuous variable.

Results

The sample population comprised 807 patients diagnosed with OSA who were admitted to the intensive care unit for the first time. The 28‐day mortality rate was 20.44%. The area under the ROC curve (AUC) for LAR was 0.730 (95% CI: 0.686–0.772), which was comparable with OASIS (0.736; 95% CI: 0.695–0.776) and superior to SOFA (0.637; 95% CI: 0.591–0.683; DeLong test p = 0.500). The optimal cutoff value for LAR was 0.791. The high‐LAR group demonstrated a poor prognosis in the K‐M analysis ( p < 0.001). Multivariate logistic regression demonstrated a significant association between LAR and unfavorable outcomes, with an odds ratio (OR) of 3.00 (95% CI: 1.83–4.90, p < 0.001) when analyzed as a dichotomous variable, and an OR of 1.52 per unit increase (95% CI: 1.27–1.82, p < 0.001) when analyzed as a continuous variable. Subgroup analysis revealed no statistically significant interaction between LAR and any subgroup ( p for interaction: 0.052–0.906).

Conclusion

LAR is a rational and easily accessible biomarker that is significantly associated with 28‐day mortality in ICU patients with OSA. These findings are only applicable to OSA patients who received lactate and albumin testing during ICU admission, and the results cannot be generalized to the entire population of ICU patients with OSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveCritical IllnessLactic AcidSerum AlbuminHumansRetrospective StudiesMaleFemaleMiddle AgedAgedPrognosisIntensive Care UnitsDatabases, FactualROC Curve

Stichwörter der Autor:innen

28-day mortalityMIMIC-IV databaseOSAbiomarkercritically illlactate-to-albumin ratiorisk factor

Substanzen

Lactic AcidSerum Albumin

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Yiwu Central Hospital, Yiwu, Zhejiang, China, ywzxyy.com.
  • Department of Laboratory Medicine, Yiwu Central Hospital, Yiwu, Zhejiang, China, ywzxyy.com.

ORCID-Profile: Jian Zhou, Chuntian Chi, Fanghao Yu, Junpei Wu, Hanjian Lou

Förderung

  • Yiwu Science and Technology Plan Project

Zitieren

APA

Zhou, J., Chi, C., Yu, F., Wu, J., & Lou, H. (2026). Association of Lactate‐to‐Albumin Ratio With 28‐Day Mortality in Critically Ill Patients With Obstructive Sleep Apnea: A Retrospective Cohort Study Based on the MIMIC‐IV Database. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/6582764

Vancouver

Zhou J, Chi C, Yu F, Wu J, Lou H. Association of Lactate‐to‐Albumin Ratio With 28‐Day Mortality in Critically Ill Patients With Obstructive Sleep Apnea: A Retrospective Cohort Study Based on the MIMIC‐IV Database. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/6582764

BibTeX
@article{Zhou2026,
  author = {Zhou, Jian and Chi, Chuntian and Yu, Fanghao and Wu, Junpei and Lou, Hanjian},
  title = {Association of Lactate‐to‐Albumin Ratio With 28‐Day Mortality in Critically Ill Patients With Obstructive Sleep Apnea: A Retrospective Cohort Study Based on the MIMIC‐IV Database},
  journal = {Canadian Respiratory Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/carj/6582764}
}
Kostenlos starten →